Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
21 Cards in this Set
- Front
- Back
prototype mixed action adrenergic agonist? its structure?
|
ephedrine
no subs on phenyl. N-methyl alpha-methyl beta-hydroxyl |
|
in general, -OH groups on the phenyl ring of agonists have what effect?
|
reduced CNS activity & reduce oral bioavailability
|
|
what drug has a direct effect at only alpha1 adrenergic receptors? its structure?
|
phenylephrine
one phenyl-OH. N-methyl, beta-OH another drug is methoxamine |
|
what drug has a direct effect at only alpha2?
|
clonidine
|
|
what drug has a direct effect at only beta1? its structure?
|
dobutamine
dopamine with another phenol-butyl type group on dopamine's N. ie huge substituent on the amine |
|
what drug has a direct effect at only beta2? its structure?
|
terbutaline (also albuterol)
3,5 phenyl-OH, N-tertbutyl, beta-OH |
|
amphetamine has no -OH groups on the phenyl, and has an alpha-methyl group. what are the effects of this?
|
no OH - orally available, access to CNS
alpha-methyl: resistant to MAO |
|
adrenergic receptor locations: alpha1
|
Vascular Smooth Muscle, pupillary dilator, pilomotor, prostate, heart (small role)
|
|
adrenergic receptor locations: alpha2
|
nerve terminals (inhibitory), fat cells to inhibit lipolysis platelets for aggregation, some VSM for contraction
|
|
adrenergic receptor locations: beta1
|
heart
|
|
adrenergic receptor locations: beta2
|
brochial SMC, uterus, VSM, liver (glycogenolysis)
|
|
adrenergic receptor locations: beta3
|
fat cells for lipolysis
|
|
adrenergic receptor locations: D1
|
dilates renal VSM
|
|
adrenergic receptor locations: D2
|
nerve terminals - modulates NT release (inhibitory, reduce cAMP levels)
|
|
describe the differences of low [Epi] vs high [Epi] acting on VSM
|
Epi binds Beta2 > Alpha1. Both exist on VSM, however, # of alpha1 > # beta2. thus, low [Epi] will vasodilate via beta2, but high [Epi] will reverse effect and vasoconstrict due to alpha1, leading to baroreflex activity and REDUCED heart rate.
|
|
an alpha1 agonist will have what effect on BP and HR? what is the prototypical alpha1 agonist?
|
phenylephrine will mostly affect VSM, where alpha1 predominates. this will increase MAP, and HR will drop from baroreflexes
|
|
what Rx would you use to reduce TPR with no immediate change in HR or CO?
|
terbutaline/albuterol, beta2agonist
(alpha 1 antagonist? prozasin?) |
|
what Rx to increase CO and contractility and VO2 with no change in TPR?
|
dobutamine, Beta1 agonist
|
|
dopamine is weird. describe its effects at low doses, then at high doses
|
low doses - mainly increases flow to kidney (via D1) and acts on heart Beta1.
high doses - activates alpha1 and increases TPR |
|
NE acts on Beta1 and alpha1, leading to increased TPR and BP. what happens to the heart rate and contractility?
|
heart rate wants to rise due to NE on Beta1, but baroreflex, via vagal nerves, slow down heart. however, the inotropic effect of NE remains
|
|
regarding NE and Epi, baroreflexes can reverse the Beta1 effects on heart. what beta1 effects are never reversed?
|
contractility (inotropic effect) and VO2 are not reversed
-thus baroreflexes-vagus n. can reverse chronotropic effect, but not inotropic effect |